FDA NEWS

Genentech's Raptiva receives new FDA warning - Seattle Times
The Food and Drug Administration said Thursday it will update the labeling of Genentech Inc.'s psoriasis drug Raptiva to highlight the risk of several bacterial and viral conditions. The added warnings follow Genentech's announcement earlier this
Source: seattletimes.nwsource.com

How Obama Would Stifle Drug Innovation - Wall Street Journal
Pfizer recently said it's exiting the development of drugs for common conditions like heart disease. This is part of a shift underway in the pharmaceutical industry to give up on routine medical problems in favor of discovering "specialty" drugs for
Source: online.wsj.com

Family Blames Soldier's Suicide on Anti-Malaria Drug - Washington Post
Susana Ferro, shown with her son Juan "John" Torres before he deployed for Afghanistan, blames the anti-malaria drug Lariam for his 2004 suicide. (Courtesy of Susana Ferro) CHICAGO -- Juan Torres didn't believe that his son, Army Reservist Juan "John
Source: www.washingtonpost.com

Merck expands international cholesterol drug study to get faster - Minneapolis Star Tribune
TRENTON, N.J. - Merck & Co. is expanding an already-large study of an experimental cholesterol drug — rejected this spring by U.S. regulators — to get results sooner so it can move up its second bid for approval. The drug, known as MK-0524A
Source: www.startribune.com

More Delays For Lilly's Heart Drug - Forbes
Prasugrel, an experimental drug that is key to pharmaceutical company Eli Lilly 's future, may be delayed months longer than investors expected. The Food and Drug Administration has asked cardiologists to mark some time in their calendars for a
Source: www.forbes.com

Ailing Democratic donor obtains experimental drug - NWITimes.com
DALLAS - An ailing Democratic fundraiser has obtained an experimental cancer-fighting drug through the Mayo Clinic, according to his son, despite the drug maker's refusal to sanction the treatment. Fred Baron, a prominent political donor linked to
Source: nwitimes.com

HHS Preparing to Open FDA Offices in China, India, Europe, and Latin - WebWire
The U.S. Department of Health and Human Services will send the first U.S. Food and Drug Administration (FDA) staff to China, India, Europe, and Latin America before the end of 2008, HHS Secretary Mike Leavitt announced today. “We’re making steady
Source: www.webwire.com